📊 Industry Moves
Whoop‘s Blood Pressure Insights cleared FDA review by getting reclassified as wellness instead of medical, so Whoop avoids validation costs and users keep the feature. The tradeoff: it’s good for trend spotting but shouldn’t replace clinical BP monitoring.
Marty’s Take:
What the industry is calling a Whoop win is actually the FDA writing a playbook for every wearable maker watching. Frame a cardiovascular feature as “wellness,” not medical, and you skip clinical validation entirely. Garmin, Samsung, and Google now have a template. That precedent helps manufacturers far more than the people trusting their fitness tracker for real health signals.
Shop mentioned gear: Whoop
Source: MobiHealthNews





